K sparing diuretics list
Pro Research Analysisby 
Searched over 200M research papers
Comprehensive List of Potassium-Sparing Diuretics
Potassium-sparing diuretics are a class of medications that help the body expel water and sodium while retaining potassium. These diuretics are often used in combination with other diuretics to prevent hypokalemia (low potassium levels). Below is a detailed list of commonly used potassium-sparing diuretics, along with their mechanisms and clinical applications.
Spironolactone: Aldosterone Antagonist
Spironolactone is a widely used potassium-sparing diuretic that works by antagonizing aldosterone receptors in the distal nephron. This action inhibits sodium reabsorption and potassium excretion, making it effective in reducing potassium loss during diuretic therapy1 3. Spironolactone is particularly useful in conditions like hypertension, heart failure, and certain cases of renal disease5.
Amiloride: Sodium Channel Blocker
Amiloride is another potassium-sparing diuretic that blocks sodium channels in the distal tubule and collecting duct. This inhibition reduces sodium reabsorption and potassium excretion, making it effective in maintaining serum potassium levels4 6. Amiloride is often used in combination with thiazide or loop diuretics to counteract potassium loss7.
Triamterene: Sodium Channel Blocker
Triamterene functions similarly to amiloride by inhibiting sodium channels in the distal nephron, thereby reducing sodium reabsorption and potassium excretion. However, studies have shown that triamterene may be less effective than amiloride in certain dosages1 6. It is commonly used in combination with other diuretics to prevent hypokalemia.
Combination Therapies: Enhanced Efficacy
Combining potassium-sparing diuretics with other diuretic classes, such as thiazides or loop diuretics, can enhance their efficacy while minimizing adverse effects like hypokalemia and hyperglycemia. For instance, combining thiazides with potassium-sparing diuretics has been shown to improve blood pressure control and reduce the incidence of hypokalemia7. This combination is particularly beneficial in treating hypertension and heart failure9.
Clinical Applications and Considerations
Potassium-sparing diuretics are often used in patients with conditions that predispose them to hypokalemia, such as those on peritoneal dialysis or those with chronic kidney disease3 5. They are also beneficial in managing conditions like heart failure and hypertension, where maintaining potassium balance is crucial9 10. However, clinicians must monitor serum potassium levels to avoid hyperkalemia, especially when these diuretics are used in combination with other medications like ACE inhibitors10.
Conclusion
Potassium-sparing diuretics, including spironolactone, amiloride, and triamterene, play a crucial role in managing conditions that require diuretic therapy while maintaining potassium balance. Their use in combination with other diuretics enhances therapeutic efficacy and minimizes adverse effects, making them invaluable in clinical practice. Monitoring and appropriate dosing are essential to maximize benefits and minimize risks.
Sources and full results
Most relevant research papers on this topic
Potassium-sparing Agents during Diuretic Therapy in Hypertension
Spironolactone reduces potassium loss during diuretic therapy, while Slow-K completely restores potassium deficits in hypertensive patients.
Non-RCTLoop diuretics are K+-sparing in the presence of a low-Na+, high-K+ diet.
Loop diuretics can be K+-sparing in mice fed a low-Na+, high-K+ diet, suggesting potential elevations in plasma K+ should be monitored when using them with a low-Na+, high-K+ diet.
Rigorous JournalClinical Utility of Potassium-Sparing Diuretics to Maintain Normal Serum Potassium in Peritoneal Dialysis Patients
Potassium-sparing diuretics effectively maintain normal serum potassium levels in peritoneal dialysis patients and decrease the need for oral potassium supplements.
Observational StudyThe potassium-sparing and natriuretic activity of N-amidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride dihydrate (amiloride hydrochloride).
Amiloride hydrochloride increases sodium excretion and decreases potassium excretion, with a unique mode of action distinct from aldosterone antagonists or organomercurial diuretics.
Non-RCT
Animal Study
Highly CitedDiuretic use in renal disease
Diuretics effectively control extracellular fluid volume in renal diseases, reducing protein excretion and reducing the risk of hyperkalemia, but caution is needed due to potential biochemical disturbances.
Highly CitedClinical evaluation of amiloride, a potassium‐sparing diuretic
Amiloride is a potassium-sparing diuretic with greater natriuretic and potassium-sparing efficacy than triamterene, providing better fluid retention treatment than triamterene.
Non-RCTThiazide diuretics alone or combined with potassium-sparing diuretics to treat hypertension: a systematic review and network meta-analysis of randomized controlled trials
Thiazide diuretics alone or combined with potassium-sparing diuretics effectively lower blood pressure, but may increase uric acid levels and increase the risk of nonmelanoma skin cancer.
Meta-AnalysisMagnesium and potassium-sparing diuretics.
Diuretic therapy can cause excessive urinary loss of magnesium, and Mg-sparing diuretics may help counteract this side effect.
Comparative mechanisms of action of diuretic drugs in hypertension
Diuretic drugs reduce blood pressure by affecting sodium and potassium levels in the kidneys, but their exact mechanism of action remains unclear.
Safety of concomitant potassium-sparing diuretics in angiotensin-converting enzyme inhibitor therapy in severe congestive heart failure. Xamoterol in Severe Heart Failure Study Group.
Concomitant use of potassium-sparing diuretics with ACE inhibitors in severe heart failure patients is safe, but serum potassium levels should be monitored as with other diuretics.
RCT
Large Human Trial